News

MediBuddy, DocsApp announce merger, Raise 150 Cr From Marquee Investors

Joint entity will utilise funding to further strengthening business

Bengaluru: DocsApp, online doctor consultation platform and MediBuddy, digital consumer health for enterprises, today announced their merger and funding. The joint entity will be India’s largest and most comprehensive digital healthcare platform, the company said. Satish Gidugu, CEO, Medi Assist, said,“Combining the capabilities of DocsApp and MediBuddy will deliver an on-demand healthcare platform providing exceptional customer experience for both enterprise and retail users.”

The entity has attracted $20 Million (~150 Crore INR) in Series B round of funding led by Bessemer Venture Partners, Fusian Capital, Mitsui Sumitomo (MSIVC) and Beyond Next ventures. Existing investors including Milliways Ventures and Rebright Partners also participated in this round.

Satish Kannan, CEO of the merged entity said,“As first-movers, we are confident that we will establish market leadership and fulfil our mission to provide quality healthcare to every Indian.” Combining their respective strengths, the joint entity is well-positioned to take a leadership position in enabling 24×7 access to healthcare.

The platforms will continue to focus on enabling healthcare services like online specialist doctor consultations, lab tests, preventive health checks, delivery of medicines etc. to customers across India.
Together, the combined entity is servicing the healthcare needs of over 3 crore Indians, with a partner network of
over 90,000 doctors, 7000 hospitals, 3000 diagnostic centres and 2500 pharmacies covering over 95% of all pin
codes in India.

The joint entity will utilize the funding in further strengthening its doctor base, patient reach, product and
technology to move a step closer to its mission of providing high-quality healthcare to a billion people.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close